See All Pediatric Endocrinologists in Bethesda, MD
Dr. Rachel Gafni, MD

Dr. Rachel Gafni, MD

Age 53 Pediatric Endocrinology F


Dr. Rachel Gafni, MD is a pediatric endocrinology specialist in Bethesda, MD. Dr. Gafni completed a residency at Chldrns Hosp. Dr. Gafni is board certified in Pediatric Endocrinology.


  1. Practice

    1. 1
      30 Convent Dr Bld Rm 228, Bethesda, MD 20892


  • Nat Inst Hlth, Fellowship Hospital — 1997
  • Chldrns Hosp, Residency Hospital — 1995
  • Temple University School of Medicine, Medical School — 1992

Insurance Accepted

  • Anthem Blue Cross Blue Shield
  • Blue Cross Blue Shield
  • CareFirst Blue Cross Blue Shield

* Please verify this information when scheduling an appointment.

Patient Satisfaction

Likelihood to recommend Dr. Gafni
Based on 1 Reviews
5 Stars
4 Stars
3 Stars
2 Stars
1 Star

Leave a review

How likely are you to recommend Dr. Gafni?

(Select your rating)
See more reviews on Healthgrades
Photo: Dr. Rachel Gafni, MD
Dr. Rachel Gafni, MD
  • Likelihood of recommending Dr. Gafni to family and friends
  • Tell us about your experience with Dr. Gafni

Dr. Gafni's Office & Staff

  • Ease of scheduling urgent appointments
  • Office environment, cleanliness, comfort, etc.
  • Staff friendliness and courteousness
  • Total wait time (waiting & exam rooms)

Experience with Dr. Gafni

  • Level of trust in provider's decisions
  • How well provider explains medical condition(s)
  • How well provider listens and answers questions
  • Spends appropriate amount of time with patients

Tell Us About Yourself

  • Display Name:
  • City, State:
  • Your gender:
  • Your age group:
  • Number of office visits you've had in the last 2 years:

Finish Here

  • How would you like to confirm your survey information?
  • Phone Number:
    Standard text messaging and data rates may apply.
Thank you for sharing your feedback about Dr. Rachel Gafni, MD.
You Might Also Like
People with type 1 diabetes may now be able to worry less about irritating blood sugar checks and unpredictable symptoms. A new “artificial pancreas” has just been approved by the Food and Drug Administration (FDA) and is expected to hit marke...